HR 475
A Resolution recognizing the month of September 2026 as "ITP Awareness Month" in Pennsylvania.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This resolution designates September 2026 as "ITP Awareness Month" in Pennsylvania. It highlights the rare autoimmune disease Immune Thrombocytopenia (ITP), characterized by low platelet counts, which can lead to bleeding and fatigue. The resolution aims to raise awareness about ITP, encourage research into better treatments and potential cures, and support individuals living with the condition. Recognizing the challenges associated with diagnosis and treatment, the resolution underscores the importance of spreading awareness for rare autoimmune diseases.
Key provisions
- Designates September 2026 as "ITP Awareness Month" in Pennsylvania.
- Recognizes Immune Thrombocytopenia (ITP) as a rare autoimmune disease.
- Details potential symptoms of ITP, including bruising, bleeding, and fatigue.
- Notes the difficulty in diagnosing ITP due to the lack of specific tests.
- Describes the three phases of ITP (newly diagnosed, persistent, and chronic).
- Highlights the variable recovery rates for adults compared to children.
- Suggests precautions for individuals with ITP, such as avoiding contact sports and certain medications.
- Acknowledges the prevalence of ITP in the United States (over 50,000 individuals).
Who is affected
- Individuals with Immune Thrombocytopenia (ITP)
- Families and caregivers of individuals with ITP
- Healthcare professionals involved in the diagnosis and treatment of ITP
- Researchers studying ITP
- Pennsylvania residents
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Benjamin Sanchez
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours